1,784 results on '"Roberts, Lewis R."'
Search Results
2. Contributors
3. Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response
4. Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)
5. Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort
6. Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma.
7. Metabolome-wide association identifies altered metabolites and metabolic pathways in the serum of patients with cholangiocarcinoma
8. Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)
9. Multitrait genome-wide analyses identify new susceptibility loci and candidate drugs to primary sclerosing cholangitis
10. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
11. Development of a Computer-aided Prediction Tool for Evaluating Brushing Samples of Biliary Strictures
12. Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study
13. Comparison of Surgical Resection and Systemic Treatment for Hepatocellular Carcinoma with Vascular Invasion: National Cancer Database Analysis
14. PKCλ/ι Loss Induces Autophagy, Oxidative Phosphorylation, and NRF2 to Promote Liver Cancer Progression
15. MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells
16. Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma
17. Prognostication of ß-catenin (CTNNB1) in patients with HCC treated with first line immunotherapy.
18. Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma
19. Hepatocellular Carcinoma
20. Cholangiocarcinoma
21. Fibrolamellar Carcinoma
22. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
23. Decreasing Trend of Serum α-Fetoprotein Level in Hepatocellular Carcinoma
24. Incidence and Long-Term Outcomes of Biliary Tract Cancers in Olmsted County, Minnesota from 1976 to 2018.
25. Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma
26. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
27. Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta‐analysis
28. Molecular testing for the clinical diagnosis of fibrolamellar carcinoma
29. AASLD guidelines for the treatment of hepatocellular carcinoma
30. A Novel Blood-Based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular Carcinoma
31. Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts
32. Genome-wide association study identifies high-impact susceptibility loci for HCC in North America
33. Using cell-free DNA for HCC surveillance and prognosis
34. Hepatitis B Screening of At-Risk Immigrants Seen at Primary Care Clinics: A Quality Improvement Project
35. BALAD and BALAD-2 predict survival of hepatocellular carcinoma patients: a North American cohort study
36. Understanding the genetic basis for cholangiocarcinoma
37. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.
38. Morphological heterogeneity in beta-catenin mutated hepatocellular carcinomas: implications for tumor molecular classification
39. Quality of Care in Patients With Cirrhosis: Trends in Recommended Adult Vaccination Coverage
40. Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine
41. SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma
42. Racial and ethnic disparities in untreated patients with hepatitis C virus‐related hepatocellular carcinoma but not in those with sustained virologic response
43. p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer
44. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles
45. Children with Chronic Hepatitis B in the United States and Canada
46. Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy
47. Role of Killer cell immunoglobulin-like receptors (KIR) genes in stages of HIV-1 infection among patients from Burkina Faso
48. Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection
49. Lymphocyte to monocyte ratio-based nomogram for predicting outcomes of hepatocellular carcinoma treated with sorafenib
50. Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.